BOLD Longevity Growth Fund
VC Fund
Boston, United States
BOLD Longevity Growth Fund is a VC fund in Boston focused on Biotechnology and Medical. BOLD Longevity Growth Fund invests in frontier biotechnologies that target the root causes of diseases and focus on longevity. The fund operates within the investment management sector, using private equity and venture capital to support biotechnology ventures. It seeks to contribute to the development of treatments intended to extend healthy lifespans.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
- Fund size:
- $58M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries BOLD Longevity Growth Fund invests in
Stages BOLD Longevity Growth Fund invests in
Countries BOLD Longevity Growth Fund invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Peter Diamandis
|
|||
Investment Focus
Industry
- Biotechnology 2 (100%)
- Medical 1 (50%)
- Wellness 1 (50%)
- Pharmaceutical 1 (50%)
- Machine Learning 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Sergey Young
Co-Founder
|
Co-Founder | Total investments: 2 | Find email | |
George Kikvadze
Limited Partner
|
Limited Partner | Total investments: 1 | Find email | |
|
Peter Diamandis
Co-Founder
|
Co-Founder | Total investments: 12 | Find email | |
Teymour Boutros-Ghali
Co-Founder
|
Co-Founder | Total investments: 12 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Matchpoint is a biotechnology company harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. The company's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning, and covalent chemistry libraryevolution. Matchpoint has an emerging pipeline of novel covalent medicines, initially focused on immunology. | $150M / Series B / Oct 07, 2026 | ||
| Aqtual is a biotechnology diagnostics platform that provides healthcare solutions, novel technology and biochemistry for chronic disease. | $31M / Series B / Jul 10, 2025 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does BOLD Longevity Growth Fund invest in?
BOLD Longevity Growth Fund invests primarily in Biotechnology, Medical and Wellness startups, most often at Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact BOLD Longevity Growth Fund?
Public channels for BOLD Longevity Growth Fund include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at BOLD Longevity Growth Fund?
The team at BOLD Longevity Growth Fund includes Sergey Young (Co-Founder), George Kikvadze (Limited Partner) and Peter Diamandis (Co-Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
